| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 132,2 k € | -24.9% | 176,1 k € | +73.2% | 101,7 k € | +8.1% | 94,1 k € | +48.1% | 63,5 k € | +49.5% | 42,5 k € | +2.3% | 41,5 k € | -22.2% | 53,4 k € | -19.3% | 66,1 k € | -35.0% | 101,7 k € | +72.9% | 58,8 k € | +48.8% | 39,5 k € | -28.4% | 55,2 k € | +81.1% | 30,5 k € | +49.1% | 20,5 k € | +9.4% | 18,7 k € | +18.7% | 15,8 k € | -9.1% | 17,3 k € | +181.0% | 6,2 k € | |
| EBITDA | 131,7 k € | -25.0% | 175,7 k € | +73.4% | 101,3 k € | +8.1% | 93,7 k € | +48.4% | 63,2 k € | +48.7% | 42,5 k € | +3.1% | 41,2 k € | -22.3% | 53,0 k € | -19.4% | 65,8 k € | -35.1% | 101,3 k € | +73.4% | 58,4 k € | +49.1% | 39,2 k € | -28.5% | 54,8 k € | +82.3% | 30,1 k € | +50.2% | 20,0 k € | +9.6% | 18,3 k € | +19.2% | 15,3 k € | -9.3% | 16,9 k € | +194.8% | 5,7 k € | |
| Operating profit | 131,7 k € | -25.0% | 175,7 k € | +73.4% | 101,3 k € | +8.1% | 93,7 k € | +48.4% | 63,2 k € | +48.7% | 42,5 k € | +3.1% | 41,2 k € | -22.3% | 53,0 k € | -19.4% | 65,8 k € | -35.1% | 101,3 k € | +73.4% | 58,4 k € | +49.1% | 39,2 k € | -28.5% | 54,8 k € | +82.3% | 30,1 k € | +50.2% | 20,0 k € | +9.6% | 18,3 k € | +19.2% | 15,3 k € | -9.3% | 16,9 k € | +194.8% | 5,7 k € | |
| Profit/loss | 94,0 k € | -26.3% | 127,6 k € | +70.1% | 75,0 k € | +7.1% | 70,0 k € | +46.0% | 48,0 k € | +66.7% | 28,8 k € | +0.6% | 28,6 k € | -19.1% | 35,4 k € | -20.4% | 44,4 k € | -34.7% | 68,0 k € | +75.2% | 38,8 k € | +49.9% | 25,9 k € | -28.3% | 36,1 k € | +93.9% | 18,6 k € | +42.0% | 13,1 k € | +17.1% | 11,2 k € | +18.6% | 9,4 k € | -8.9% | 10,4 k € | +95.7% | 5,3 k € | |
| Equity | 255,0 k € | +62.9% | 156,5 k € | +58.3% | 98,9 k € | +5.4% | 93,8 k € | +0.0% | 93,8 k € | +27.0% | 73,9 k € | +1.1% | 73,1 k € | +0.8% | 72,5 k € | +11.3% | 65,1 k € | +7.3% | 60,7 k € | +42.2% | 42,7 k € | -2.7% | 43,8 k € | +23.3% | 35,6 k € | +20.7% | 29,4 k € | +9.8% | 26,8 k € | +18.6% | 22,6 k € | +11.3% | 20,3 k € | +2.7% | 19,8 k € | +8.0% | 18,3 k € | |
| Total assets | 474,4 k € | +44.4% | 328,5 k € | +31.3% | 250,3 k € | +21.0% | 206,9 k € | +7.8% | 191,9 k € | +50.5% | 127,5 k € | -44.4% | 229,3 k € | +34.6% | 170,3 k € | +4.6% | 162,8 k € | -21.5% | 207,5 k € | +98.5% | 104,5 k € | +18.0% | 88,6 k € | -24.6% | 117,5 k € | +60.8% | 73,1 k € | +16.1% | 62,9 k € | +46.5% | 43,0 k € | +6.0% | 40,5 k € | +29.8% | 31,2 k € | +8.2% | 28,9 k € | |
| Cash | 30,0 k € | -78.1% | 136,8 k € | +23.9% | 110,5 k € | -20.2% | 138,4 k € | +46.6% | 94,4 k € | -25.9% | 127,5 k € | +8671.6% | 1,5 k € | -68.7% | 4,6 k € | -73.9% | 17,8 k € | +96.5% | 9,0 k € | -70.6% | 30,7 k € | +367.1% | 6,6 k € | -84.6% | 42,8 k € | +85.5% | 23,1 k € | +233.2% | 6,9 k € | -77.9% | 31,3 k € | +39.6% | 22,4 k € | -27.1% | 30,8 k € | +1539500.0% | 2,0 € | |
| Debts | 219,4 k € | +27.6% | 172,0 k € | +13.6% | 151,4 k € | +33.9% | 113,1 k € | +15.7% | 97,7 k € | +83.5% | 53,2 k € | -65.8% | 155,8 k € | +59.8% | 97,5 k € | +0.2% | 97,3 k € | -33.6% | 146,4 k € | +138.3% | 61,4 k € | +38.5% | 44,4 k € | -45.6% | 81,5 k € | +88.6% | 43,2 k € | +21.1% | 35,7 k € | +78.9% | 20,0 k € | +0.6% | 19,8 k € | +79.2% | 11,1 k € | +4.8% | 10,6 k € | |
Private limited company · Woluwe-Saint-Pierre · incorporated on 11/04/1991
Private limited company profitable and well capitalised. Cash position declining (-78.1%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
BIOTECH is a Private limited company incorporated in 1991. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Woluwe-Saint-Pierre.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette